Beck Mack & Oliver’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,551
Closed -$402K 200
2025
Q4
$402K Buy
4,551
+31
+0.7% +$2.82K 0.01% 145
2025
Q3
$407K Buy
4,520
+39
+0.9% +$3.16K 0.01% 141
2025
Q2
$340K Buy
4,481
+41
+0.9% +$3.04K 0.01% 150
2025
Q1
$317K Buy
4,440
+33
+0.7% +$2.57K 0.01% 154
2024
Q4
$387K Buy
4,407
+33
+0.8% +$2.89K 0.01% 139
2024
Q3
$366K Buy
4,374
+35
+0.8% +$2.8K 0.01% 139
2024
Q2
$330K Buy
4,339
+39
+0.9% +$2.88K 0.01% 142
2024
Q1
$309K Buy
4,300
+34
+0.8% +$2.44K 0.01% 144
2023
Q4
$319K Buy
+4,266
New +$305K 0.01% 144

Other funds holding SRE

Beck Mack & Oliver's SRE Position: Q1 2026 in Review

Beck Mack & Oliver sold out of Sempra (SRE) in Q1 2026, closing a stake of 4,551 shares — an estimated $402K sold.

Beck Mack & Oliver first reported a position in SRE in Q4 2023 and held it in 9 quarters. The position peaked at $407K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold SRE as of Q1 2026.

  • Beck Mack & Oliver reported no remaining Sempra position as of Q1 2026 after selling out during the quarter.
  • Beck Mack & Oliver sold 4,551 Sempra shares in Q1 2026, an estimated $402K.
  • Beck Mack & Oliver first reported a position in Sempra in Q4 2023 and held it in 9 quarters.
  • Beck Mack & Oliver's Sempra position peaked at $407K in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Sempra as of Q1 2026.

Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.